Home
News
Press Kit

Media Press Kit

Explore hVIVO’s media and press kit, featuring company information, brand assets, and key resources for journalists, partners, and stakeholders. For further enquiries or tailored materials, please get in touch with our team.

hVIVO is a full-service early phase contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials.

Explore valuable resources below, featuring the most recent hVIVO plc investor presentation, officially approved company descriptions, and captivating images suitable for editorial use, provided the association with hVIVO, Venn Life Sciences, CRS, hLAB, Cryostore, and FluCamp is prominently identifiable. Please note that commercial usage is strictly prohibited.

hVIVO Description

hVIVO plc (Ticker: HVO) is a full-service early phase Contract Research Organisation (CRO) and the global leader in human challenge trials. The Company delivers end-to-end clinical development services to a diverse and expanding client base, including seven of the world’s ten largest biopharma companies.

hVIVO specialises in conducting human challenge trials across multiple infectious and respiratory indications, leveraging its state-of-the-art quarantine facility in London—the largest of its kind worldwide. The Company also offers comprehensive virology and immunology laboratory services.

Through its German subsidiary, CRS, hVIVO operates a 120-bed capacity across Mannheim and Kiel, providing early-phase clinical trial services, including first-in-human and proof-of-concept studies. Its second subsidiary, Venn Life Sciences, offers Early Drug Development Consulting and Biometry services to the biopharma sector.

The Group provides fully integrated drug development solutions from preclinical stages through Phase II trials, alongside patient recruitment via FluCamp. Additionally, its five clinical sites support outpatient Phase II and III trials, ensuring a seamless and efficient pathway from discovery to late-stage development.

hVIVO Integrated Service Platform

hVIVO combines deep scientific expertise, purpose-built facilities, and end-to-end clinical capabilities to support biopharma clients at every stage of development. From consultancy and trial design to laboratory services, human challenge trials, recruitment, and secure sample storage, our integrated platform ensures efficient, high-quality delivery across complex therapeutic areas, enabling faster decision-making and more predictable outcomes.

Your clinical development partner

hVIVO is a full-service, early-phase clinical development partner and the global leader in human challenge trials. With integrated capabilities spanning consultancy, clinical trials, laboratory services, recruitment, and storage, the Company supports biopharma clients in accelerating development timelines and generating high-quality data. Its purpose-built facilities and expert-led approach enable efficient, end-to-end delivery across complex therapeutic areas.

German site_ T.Frost with patient Copyright by Julia Berlin_RAW__Y6A6414

About us

Delivering trials across all phases

hVIVO delivers clinical trial services across Phase I to Phase III, supporting the progression of therapies from first-in-human studies through to later-stage development. With specialist expertise in early-phase and complex study designs, the Company provides efficient trial execution, high-quality data, and seamless integration with laboratory and recruitment capabilities to optimise outcomes and accelerate development programmes.

Learn more

Strategic guidance at every stage

hVIVO’s consultancy services provide strategic and scientific guidance across the clinical development lifecycle. From regulatory strategy and trial design to due diligence and investor readiness, the team supports clients in making informed decisions at every stage. Combining deep therapeutic expertise with practical delivery experience, hVIVO helps optimise development pathways and reduce risk.

Learn more

Advanced laboratory capabilities

hVIVO offers comprehensive laboratory services to support clinical trials and translational research, including bioanalytical testing, virology, immunology, and biomarker analysis. Its state-of-the-art facilities, including CL3 laboratories, enable high-quality sample processing and data generation. Fully integrated with clinical operations, these capabilities ensure consistency, speed, and scientific rigour across studies.

Learn more

Decades of experience

hVIVO is the global leader in human challenge trials, with a heritage dating back decades and unmatched operational expertise. These studies involve the controlled exposure of volunteers to pathogens to generate early efficacy data, enabling faster and more cost-effective decision-making. hVIVO’s purpose-built quarantine facilities and specialist models support a wide range of infectious diseases.

Learn more

Secure and compliant storage

hVIVO provides secure, compliant storage solutions for biological samples and clinical materials through its specialist cryostorage capabilities. With robust infrastructure and quality-controlled processes, the Company ensures the integrity and traceability of samples across the clinical development lifecycle. These services are fully integrated with laboratory and clinical operations for seamless handling and access.

hVIVO_Lab_Services_Liquid_Nitrogen_Storage-1

Learn more

Industry-leading recruitment

hVIVO delivers industry-leading participant recruitment through its dedicated platform, FluCamp. hVIVO has one of the largest volunteer databases in Europe. With a strong track record of rapid enrolment and high retention, the Company ensures studies are delivered on time and to target. Its recruitment capabilities are closely aligned with clinical operations to support efficient trial execution.